Rigel Pharmaceuticals, Inc. (RIGL) Stock Falls -0.96% This Week: Is It a Good Pick?

Rigel Pharmaceuticals, Inc. (RIGL) stock is down -13.85% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives RIGL stock a score of 77 out of a possible 100.

That rank is primarily influenced by a fundamental score of 88. In addition to the average rating from Wall Street analysts, RIGL stock has a mean target price of $7.40. This means analysts expect the stock to gain 137.94% over the next 12 months. RIGL's rank also includes a long-term technical score of 81. The short-term technical score for RIGL is 63.

RIGL has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on RIGL!

See Full RIGL Report

What's Happening with RIGL Stock Today

Rigel Pharmaceuticals, Inc. (RIGL) stock has gained 5.61% while the S&P 500 has gained 0.11% as of 10:44 AM on Wednesday, Apr 13. RIGL has gained $0.16 from the previous closing price of $2.94 on volume of 362,666 shares. Over the past year the S&P 500 is higher by 6.30% while RIGL is down -13.85%. RIGL lost -$0.11 per share in the over the last 12 months. Click Here to get the full Stock Report for Rigel Pharmaceuticals, Inc. stock.